CONTACT
+91 80 2808 2808
ContactUs.BBL@biocon.com
Biocon Biologics  /  Businesses  /  Generics  /  Portfolio

GENERIC FORMULATIONS

Strategy: Portfolio

We are developing a select portfolio of complex generic formulations where the complexity is a challenge either due to the API or the formulation or both. For formulations that require vertical integration and economy of scale, we will leverage our large-scale API manufacturing infrastructure.

Our products

The dosage forms in our portfolio include:

Oral Solids (Potent and Non-Potent)
Injectable
Device Dependent Formulations

Siddharth Mittal
KEY MANAGEMENT TEAM
PRODUCTS
PRESS RELEASES
CORPORATE GOVERNANCE
R&D
WORKING WITH US
Share